Papillary thyroid carcinoma, parathyroid adenoma, and unexplained hypercalcitoninemia: An unusual presentation of multiple endocrine neoplasia type 2A?

Thyroid

Volumn 8, Issue 9, 1998, Pages 781-785

  Rone, James K ^a,c   Lane, Alexis G ^a   Grinkemeyer, Michael D ^b  

^a USAF Medical Center Keesler   (United States)

^b KEESLER MEDICAL CENTER   (United States)

^c Murfreesboro Medical Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN;

ADULT; ARTICLE; CALCITONIN BLOOD LEVEL; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERPARATHYROIDISM; PARATHYROID ADENOMA; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; SIPPLE SYNDROME; THYROID MEDULLARY CARCINOMA; THYROID PAPILLARY CARCINOMA;

EID: 0031729019     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.1998.8.781     Document Type: Article

References (39)

1. Sizemore GW 1995 Multiple endocrine neoplasia. In: Backer KL (ed) Principles and Practice of Endocrinology and Metabolism. 2nd edition. Lippincott, Philadelphia, pp 1555-1564.
2. Wohllk N, Cote GJ, Evans DB, Goepfert H, Ordonez NG, Gagel RF 1996 Application of genetic screening information to the management of medullary thyroid carcinoma and multiple endocrine neoplasia type 2. Endocrinol Metab Clin North Am 25:1-25.
3. Becker KL, Nylen ES, Cohen R, Silva OL, Snider RH 1995 Calcitonin gene family of peptides. In: Becker KL (ed) Principles and Practice of Endocrinology and Metabolism. 2nd edition. Lippincott, Philadelphia, pp 474-483.
4. Mazzaferri EL 1995 Thyroid cancer. In: Becker KL (ed) Principles and Practice of Endocrinology and Metabolism. 2nd edition. Lippincott, Philadelphia, pp 354-366.
5. Ball DW, Baylin SB, de Bustros AC 1996 Medullary thyroid carcinoma. In: Braverman LE, Utiger RD (eds) Werner and Ingbar's The Thyroid. 7th edition. Lippincott-Raven, Philadelphia, pp 946-960.
6. Niccoli P, Wion-Barbot N, Caron P, Henry J-F, De Micco C, Saint Andre J-P, Bigorgne J-C, Modigliani E, Conte-Devolx B, and the French Medullary Study Group 1997 Interest of routine measurement of serum calcitonin: study in a large series of thyroidectomized patients. J Clin Endocrinol Metab 82:338-341.
7. Pacini F, Fontanelli M, Fugazzola L, Elisei R, Romei C, Di Coscio G, Miccoli P, Pinchera A 1994 Routine measurement of serum calcitonin in nodular thyroid diseases allows the preoperative diagnosis of unsuspected sporadic medullary thyroid carcinoma. J Clin Endocrinol Metab 78:826-829.
8. Ogburn PL, Black BM 1956 Primary hyperparathyroidism and papillary adenocarcinoma of the thyroid: report of four cases. Proc Staff Meet Mayo Clin 31:295-298.
9. Attie JN, Vardan R 1993 Association of hyperparathyroidism with nonmedullary thyroid carcinoma: review of 31 cases. Head Neck 15:20-23.
10. Alexander MJ 1995 The occurrence of thyroid carcinoma in San Francisco. N Engl J Med 253:45-49.
11. Hazard JB, Kaufman N 1952 A survey of thyroid gland obtained at autopsy in a so-called goiter area. Am J Clin Pathol 22:860-865.
12. Sokol JE 1953 Occurrence of thyroid cancer. N Engl J Med 249:393-397.
13. Fedorak IJ, Salti G, Fulton N, Schark C, Straus FH II, Kaplan EL 1994 Increased incidence of thyroid cancer in patients with primary hyperparathyroidism: A continuing dilemma. Am Surg 60:427-431.
14. Simpson RJ, Moss J 1989 Parathyroid adenoma and nonmedullary thyroid carcinoma association. Otolaryngol Head Neck Surg 101:584-587.
15. Lever EG, Refetoff S, Straus FH II, Nguyen M, Kaplan EL 1983 Coexisting thyroid and parathyroid disease - Are they related? Surgery 94:893-900.
16. Prinz RA, Barbato AL, Braithwhite SS, et al 1982 Simultaneous primary hyperparathyroidism and nodular thyroid disease. Surgery 92:454-458.
17. Linos DA, Heerden JA, Edis AJ 1982 Primary hyperparathyroidism and nonmedullary thyroid cancer. Am J Surg 143:301-303.
18. Hedman I, Tisell LE 1984 Associated hyperparathyroidism and nonmedullary thyroid carcinoma: The etiologic role of radiation. Surgery 95:392-397.
19. Tisell LE, Carlsson S, Lonberg S, Ragnhult I 1976 Autonomous hyperparathyroidism. Acta Chir Scand 142:367-373.
20. Decker RA 1993 Expression of papillary thyroid carcinoma in multiple endocrine neoplasia type 2A. Surgery 111:1059-1063.
21. Oishi S, Sasaki M, Sato T, Isogai M 1995 Coexistence of MEN 2A and papillary thyroid carcinoma and a recurrent pheochromocytoma 23 years after surgery; Report of a case and a review of the Japanese literature. Jpn J Clin Oncol 25:153-158.
22. Ain KB 1995 Papillary thyroid carcinoma: Etiology, assessment, and therapy. Endocrinol Metab Clin North Am 24:711-760.
23. Albores-Saavedra J, Gorraez de la Mora T, de la Torre-Rendon F, Gould E 1990 Mixed medullary-papillary carcinoma of the thyroid: A previously unrecognized variant of thyroid carcinoma. Human Pathology 21:1151-1155.
24. Noel M, Delehaye MC, Segond N, Lasmoles F, Caillou B, Gardet P, Pragu P, Moukiitar MS 1991 Study of calcitonin and thyroglobulin gene expression in human mixed follicular and medullary thyroid carcinoma. Thyroid 1:249-256.
25. Sato H, Inoue D, Koshiyama H, Takahashi H, Kakudo K 1997 Interest of routine measurement of serum calcitonin: Study of thyroidectomized patients [letter]. J Clin Endocrinol Metab 82:2755.
26. Maeda T, Ashie T, Kikuiri K, Takakura M, Ise T, Shimamoto K 1989 A case of calcitonin-producing parathyroid adenoma with primary hyperparathyroidism. Jpn J Med 28:640-646.
27. Hernandez C, Simo R, Oriola J, Mesa J 1997 False-positive results of basal and pentagastrin-stimulated calcitonin in nongene carriers of multiple endocrine neoplasia type 2A. Thyroid 7:51-54.
28. Chico A, Bernia L, Cabezas R, Webb SM, de Leivia A 1997 Octreotide scintigraphy in recurrent medullary thyroid carcinoma. Presented at the 79th annual meeting of The Endocrine Society, Minneapolis, MN.
29. Levine MA 1996 Laboratory evaluation of calcitropic hormones and minerals. In: Moore WT, Eastman RC (eds) Diagnostic Endocrinology. 2nd ed. Mosby-Yearbook, Inc., St. Louis, pp 411-438.
30. Kubler N, Krause U, Wagner PK, Beyer J, Rothmund M 1987 The effect of high parathyroid hormone concentration on calcitonin in patients with primary hyperparathyroidism. Exp Clin Endocrinol 90:324-330.
31. Brismar K, Werner S, Bucht E, Weterberg L 1987 Melatonin, cortisol, prolactin, and calcitonin secretion in primary hyperparathyroidism before and after surgery. J Pineal Res 4:277-285.
32. Farndon JR, Geraghty JM, Dilley WG, Handwerger S, Leight GS 1987 Serum gastrin, calcitonin, and prolactin as markers of multiple endocrine neoplasia syndromes in patients with primary hyperparathyroidism. World J Surg 11:252-257.
33. Mazzuoli GF, D'Erasmo E, Scarda A, Mancini D, Minisola S, Malaguti Alberti L, Valtorta C 1981 Calcitonin secretion and bone disease severity in hypercalcemic hyperparathyroidism. Clin Endocrinol 15:81-86.
34. Tabolli S, Valtorta C, Bigi F, Minisola S, Mazzuoli GF 1986 Basal and stimulated calcitonin secretion in primary hyperparathyroidism before and after parathyroidectomy. Horm Res 23:142-146.
35. Becker KL, Silva OL, Wisneski LA, Cyrus J, Snider RH, Moore CF, Higgins GA 1980 Limited calcitonin reserve in hyperparathyroidism. Am J Med Sci 280:11-15.
36. Tiegs RD, Body JJ, Barta JM, Heath H III 1986 Plasma calcitonin in primary hyperparathyroidism: Failure of C-cell response to sustained hypercalcemia. J Clin Endocrinol Metab 63:785-788.
37. Santini L, Scurini C, Caraco C, Conzo G, Orabona P, De Rosa G, Fattoruso O, Colantuoni V 1996 A primary, lateral-cervical medullary thyroid carcinoma: A case report. J Clin Endocrinol Metab 81:1784-1786.
38. Harach HR, Williams ED 1997 Thyroid medullary carcinoma occurring laterally in the neck [letter]. J Clin Endocrinol Metab 82:983-984.
39. Van Heerden JA, Grant CS, Gharib H, Hay ID, Ilstrup DM 1990 Long-term course of patients with persistent hypercalcitoninemia after apparent curative primary surgery for medullary thyroid carcinoma. Ann Surg 212:395-401.